logo
Select company
Select metric
$ -71.67MEarning Before Interest & Taxes (EBIT)
VS
Market
13
Sector
28
Industry
38
History
29
$ 3.04Close
$ 0.51 - $ 5.18 52-Week Range
Ticker Information

Ticker

PROK

Company Name

PROKIDNEY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROKIDNEY CORP - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PROK - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -71.67M
3/31/2025$ -68.53M
12/31/2024$ -61.77M
9/30/2024$ -45.11M
6/30/2024$ -34.93M
3/31/2024$ -30.52M
12/31/2023$ -29.46M
9/30/2023$ -34.3M
6/30/2023$ -36.2M
3/31/2023$ -30.33M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROKIDNEY CORP's latest trailing twelve months (TTM) EBIT stands at $ -2.32M.
  • Over the past 5 years, PROKIDNEY CORP's average EBIT has been $ -63.43M.
  • The median EBIT for PROKIDNEY CORP during this period was $ -45.11M
  • PROKIDNEY CORP reached its highest EBIT over the past 5 years at $ -2.32M.
  • The lowest EBIT recorded by PROKIDNEY CORP in the same timeframe $ -142.3M

PROKIDNEY CORP's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
SEPN : SEPTERNA INC $ -87.8MMREO : MEREO BIOPHARMA GROUP PLC $ -50.35MABEO : ABEONA THERAPEUTICS INC $ 76.89MCRDF : CARDIFF ONCOLOGY INC $ -51.02MAVTX : AVALO THERAPEUTICS INC $ -48.27MBBOT : BRIDGEBIO ONCOLOGY THERAPEUTICS INC $ -106.51MCOYA : COYA THERAPEUTICS INC $ -21.06MMNMD : MIND MEDICINE (MINDMED) INC $ -110.19MSANA : SANA BIOTECHNOLOGY INC $ -252.18MERNA : ERNEXA THERAPEUTICS INC $ -38.51M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

PROK - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -142.3M

Minimum

Jun 30, 2022

$ -2.32M

Maximum

Dec 31, 2021

$ -63.43M

Average

$ -45.11M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.64M with a standard deviation of $ 130.66M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.64M
median$ 897.02K
std$ 130.66M